New implant links insulin-producing cells to blood vessels, aiming to treat Type 1 diabetes

Researchers at McGill University and the Research Institute of the McGill University Health Center (RI-MUHC) have developed a ...
Mirage News

New Cell Transplant Method May Aid Type 1 Diabetes

Researchers at McGill University and the Research Institute of the McGill University Health Center (RI-MUHC) have developed a ...
PharmiWeb

ADOCIA Reports First Quarter 2026 Financial Results and Provides a Business Update

Cash position of €12.0 million as of March 31, 2026Shareholder loan agreement signed with Vester Finance on April 21, 2026, securing a cash runway until the beginning of Q2 2027BioChaperone®: ...
News-Medical.Net

Large human islet study reveals new insights into diabetes risk

Diabetes is the most common and serious chronic disease worldwide, characterized by insufficient insulin to maintain proper ...
ascopubs.org

Avutometinib/defactinib and gemcitabine/nab-paclitaxel combination in first-line metastatic pancreatic ductal adenocarcinoma: Initial safety and efficacy of phase 1b/2 study ...

Phase 1 study of anti–immunoglobulin-like transcript 3 (ILT3) monoclonal antibody MK-0482 + pembrolizumab + gemcitabine + nab-paclitaxel (Gem/Nab-P) in patients (pts) with metastatic pancreatic ductal ...
ascopubs.org

Early results of the PASS-01 trial: Pancreatic adenocarcinoma signature stratification for treatment-01.

Ramucirumab plus paclitaxel as switch maintenance versus continuation of oxaliplatin-based chemotherapy in patients (pts) with advanced HER2-negative gastric or gastroesophageal junction (GEJ) cancer: ...